| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | MOZART2 | 1.63e-05 | 2 | 76 | 2 | IPR024332 | |
| Domain | MOZART2 | 1.63e-05 | 2 | 76 | 2 | PF12926 | |
| Domain | FAM117 | 4.89e-05 | 3 | 76 | 2 | PF15388 | |
| Domain | Glcci1/FAM117 | 4.89e-05 | 3 | 76 | 2 | IPR026642 | |
| Domain | VG_K_chnl | 3.24e-04 | 33 | 76 | 3 | IPR028325 | |
| Domain | - | 3.26e-03 | 21 | 76 | 2 | 3.90.226.10 | |
| Domain | ClpP/crotonase-like_dom | 3.26e-03 | 21 | 76 | 2 | IPR029045 | |
| Domain | Bromodomain_CS | 4.99e-03 | 26 | 76 | 2 | IPR018359 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29955842 | ||
| Pubmed | Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. | 4.84e-06 | 2 | 77 | 2 | 9546399 | |
| Pubmed | Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression. | 4.84e-06 | 2 | 77 | 2 | 25970345 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 6.46e-06 | 444 | 77 | 8 | 34795231 | |
| Pubmed | Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition. | 1.45e-05 | 3 | 77 | 2 | 25789873 | |
| Pubmed | MZT Proteins Form Multi-Faceted Structural Modules in the γ-Tubulin Ring Complex. | 1.45e-05 | 3 | 77 | 2 | 32610146 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 22194695 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 30546041 | ||
| Pubmed | Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA. | 1.45e-05 | 3 | 77 | 2 | 23255807 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 ACACA TRA2B GIT1 ANLN FAM117B ALPK1 CDC20 GLCCI1 PALLD | 2.01e-05 | 861 | 77 | 10 | 36931259 |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 15140898 | ||
| Pubmed | Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. | 2.89e-05 | 4 | 77 | 2 | 14765198 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 25731027 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | BLVRA ERCC6 ACACA TRA2B ANLN FHOD1 EIF4G2 ACIN1 AMBRA1 CDC20 PALLD PHIP | 4.06e-05 | 1353 | 77 | 12 | 29467282 |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 28785060 | ||
| Pubmed | Histone recognition and large-scale structural analysis of the human bromodomain family. | 1.01e-04 | 7 | 77 | 2 | 22464331 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 21533022 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 30108230 | ||
| Pubmed | 1.28e-04 | 503 | 77 | 7 | 16964243 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.53e-04 | 695 | 77 | 8 | 23602568 | |
| Pubmed | Sumoylation promotes optimal APC/C Activation and Timely Anaphase. | 1.72e-04 | 9 | 77 | 2 | 29517484 | |
| Pubmed | CDK5RAP2 stimulates microtubule nucleation by the gamma-tubulin ring complex. | 2.15e-04 | 10 | 77 | 2 | 21135143 | |
| Pubmed | 2.19e-04 | 733 | 77 | 8 | 34672954 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.57e-04 | 954 | 77 | 9 | 36373674 | |
| Pubmed | GC-B Deficient Mice With Axon Bifurcation Loss Exhibit Compromised Auditory Processing. | 2.63e-04 | 11 | 77 | 2 | 30275816 | |
| Pubmed | 2.76e-04 | 963 | 77 | 9 | 28671696 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.16e-04 | 774 | 77 | 8 | 15302935 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 4.00e-04 | 432 | 77 | 6 | 23455922 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 ACACA ATXN7 KCNMA1 FAM117B VGLL4 RIMS1 SAP130 VPS13B ZNF440 KLHL26 | 4.25e-04 | 1489 | 77 | 11 | 28611215 |
| Pubmed | Identification of a small TAF complex and its role in the assembly of TAF-containing complexes. | 4.33e-04 | 14 | 77 | 2 | 17375202 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CLPP BLVRA TRA2B NISCH DACH1 TRA2A CDC20 TOR1AIP1 SLC33A1 PHIP VPS13B | 4.42e-04 | 1496 | 77 | 11 | 32877691 |
| Pubmed | 5.69e-04 | 16 | 77 | 2 | 24586484 | ||
| Pubmed | 5.80e-04 | 73 | 77 | 3 | 22094256 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.58e-04 | 475 | 77 | 6 | 31040226 | |
| Pubmed | Genetically distinct subsets within ANCA-associated vasculitis. | 7.23e-04 | 18 | 77 | 2 | 22808956 | |
| Pubmed | 7.31e-04 | 79 | 77 | 3 | 22504420 | ||
| Pubmed | 7.66e-04 | 323 | 77 | 5 | 24797263 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.01e-03 | 1155 | 77 | 9 | 20360068 | |
| Pubmed | 1.09e-03 | 22 | 77 | 2 | 27798115 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.12e-03 | 724 | 77 | 7 | 36232890 | |
| Pubmed | Tbx2 is a master regulator of inner versus outer hair cell differentiation. | 1.19e-03 | 23 | 77 | 2 | 35508658 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.19e-03 | 533 | 77 | 6 | 30554943 | |
| Pubmed | 1.24e-03 | 360 | 77 | 5 | 33111431 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.26e-03 | 361 | 77 | 5 | 30344098 | |
| Pubmed | 1.29e-03 | 24 | 77 | 2 | 20935629 | ||
| Pubmed | 1.38e-03 | 549 | 77 | 6 | 38280479 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 1.71e-03 | 106 | 77 | 3 | 31024071 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 1.76e-03 | 107 | 77 | 3 | 20508642 | |
| Pubmed | Rebalancing gene haploinsufficiency in vivo by targeting chromatin. | 1.76e-03 | 28 | 77 | 2 | 27256596 | |
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.76e-03 | 28 | 77 | 2 | 19661089 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 1.81e-03 | 233 | 77 | 4 | 32290105 | |
| Pubmed | 2.03e-03 | 403 | 77 | 5 | 35253629 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 2.10e-03 | 1284 | 77 | 9 | 17353931 | |
| Pubmed | 2.16e-03 | 31 | 77 | 2 | 20813000 | ||
| Cytoband | 13q22 | 1.51e-04 | 11 | 77 | 2 | 13q22 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 8.64e-04 | 18 | 44 | 2 | 498 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 176 | 77 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-05 | 177 | 77 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-05 | 185 | 77 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-05 | 186 | 77 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 188 | 77 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.87e-05 | 188 | 77 | 5 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-05 | 189 | 77 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-05 | 189 | 77 | 5 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-05 | 189 | 77 | 5 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.28e-05 | 196 | 77 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.52e-05 | 200 | 77 | 5 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 150 | 77 | 4 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 150 | 77 | 4 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.36e-04 | 151 | 77 | 4 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 155 | 77 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.66e-04 | 159 | 77 | 4 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 160 | 77 | 4 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 160 | 77 | 4 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 165 | 77 | 4 | 79c6ad394266ff092029375883660028e944a3c8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-04 | 168 | 77 | 4 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 169 | 77 | 4 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 169 | 77 | 4 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 169 | 77 | 4 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.15e-04 | 170 | 77 | 4 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 172 | 77 | 4 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-04 | 174 | 77 | 4 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-04 | 174 | 77 | 4 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 174 | 77 | 4 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 174 | 77 | 4 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 174 | 77 | 4 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 174 | 77 | 4 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 175 | 77 | 4 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.56e-04 | 178 | 77 | 4 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 178 | 77 | 4 | 60263c0bb9de3a57ba2ba543262a2ace0066fd85 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.67e-04 | 180 | 77 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 180 | 77 | 4 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-04 | 180 | 77 | 4 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 180 | 77 | 4 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 181 | 77 | 4 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 2.90e-04 | 184 | 77 | 4 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 2.90e-04 | 184 | 77 | 4 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-04 | 186 | 77 | 4 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-04 | 186 | 77 | 4 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 188 | 77 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.15e-04 | 188 | 77 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 189 | 77 | 4 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 189 | 77 | 4 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-04 | 190 | 77 | 4 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-04 | 190 | 77 | 4 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 3.28e-04 | 190 | 77 | 4 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.28e-04 | 190 | 77 | 4 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 191 | 77 | 4 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-04 | 191 | 77 | 4 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.34e-04 | 191 | 77 | 4 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.34e-04 | 191 | 77 | 4 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 191 | 77 | 4 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 191 | 77 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 191 | 77 | 4 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 192 | 77 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-04 | 193 | 77 | 4 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-04 | 193 | 77 | 4 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.48e-04 | 193 | 77 | 4 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.48e-04 | 193 | 77 | 4 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-04 | 193 | 77 | 4 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.48e-04 | 193 | 77 | 4 | 42775588e788c330aade07e54b208f1c2eea3ab3 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-04 | 193 | 77 | 4 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_basal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.55e-04 | 194 | 77 | 4 | b887b2ff19b76bd93c67f9a24762efae816efd45 | |
| ToppCell | HSPCs-Mk_prog.|HSPCs / Lineage and Cell class | 3.55e-04 | 194 | 77 | 4 | 5c05d508f5c29e6efe87506bf59e3b0fe5922f65 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.55e-04 | 194 | 77 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.55e-04 | 194 | 77 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.62e-04 | 195 | 77 | 4 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 77 | 4 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.69e-04 | 196 | 77 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-04 | 196 | 77 | 4 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-04 | 196 | 77 | 4 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.69e-04 | 196 | 77 | 4 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 3.76e-04 | 197 | 77 | 4 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.76e-04 | 197 | 77 | 4 | 8fa38fb95e285f9cc756ec4f32009be4ede09d3c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 197 | 77 | 4 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 197 | 77 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 3.76e-04 | 197 | 77 | 4 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 197 | 77 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-04 | 197 | 77 | 4 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.76e-04 | 197 | 77 | 4 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-04 | 197 | 77 | 4 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 197 | 77 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 3.76e-04 | 197 | 77 | 4 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.76e-04 | 197 | 77 | 4 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.76e-04 | 197 | 77 | 4 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.83e-04 | 198 | 77 | 4 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.83e-04 | 198 | 77 | 4 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.83e-04 | 198 | 77 | 4 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.83e-04 | 198 | 77 | 4 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-04 | 198 | 77 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-04 | 198 | 77 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.83e-04 | 198 | 77 | 4 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-04 | 198 | 77 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tem|Bac-SEP / Disease, condition lineage and cell class | 3.83e-04 | 198 | 77 | 4 | 292b26f316f016b50d07689f84772eec46060251 | |
| Disease | Intellectual Disability | 1.31e-04 | 447 | 74 | 7 | C3714756 | |
| Disease | Colorectal Carcinoma | 3.73e-04 | 702 | 74 | 8 | C0009402 | |
| Disease | Mental Retardation, Psychosocial | 4.20e-04 | 139 | 74 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 4.20e-04 | 139 | 74 | 4 | C0020796 | |
| Disease | Mental deficiency | 4.20e-04 | 139 | 74 | 4 | C0917816 | |
| Disease | Nonsyndromic genetic hearing loss | 9.33e-04 | 76 | 74 | 3 | cv:C5680182 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.39e-03 | 22 | 74 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | otitis media (implicated_via_orthology) | 1.39e-03 | 22 | 74 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Carcinoma of lung | 1.52e-03 | 23 | 74 | 2 | C0684249 | |
| Disease | Pseudoaphakia | 1.65e-03 | 24 | 74 | 2 | C0524524 | |
| Disease | Lens Opacities | 1.65e-03 | 24 | 74 | 2 | C1510497 | |
| Disease | retinal vasculature measurement | 1.90e-03 | 517 | 74 | 6 | EFO_0010554 | |
| Disease | macular degeneration (is_marker_for) | 1.94e-03 | 26 | 74 | 2 | DOID:4448 (is_marker_for) | |
| Disease | hearing impairment | 1.94e-03 | 98 | 74 | 3 | C1384666 | |
| Disease | Bell's palsy | 2.18e-03 | 102 | 74 | 3 | EFO_0007167 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.25e-03 | 28 | 74 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.41e-03 | 29 | 74 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANPRGRPKMGSRSTS | 621 | Q9UKV3 | |
| SRQRRPGNFSHSLDM | 11 | O00400 | |
| SERSHRSPSGMRQGR | 1881 | Q68DN1 | |
| SPMRAANRSHSAGRT | 41 | Q12834 | |
| GQSAQAMASRHRPRP | 181 | Q9NTK1 | |
| SRNRHSANPNPRLHM | 401 | Q01954 | |
| TSHPNRGNIPTLNRM | 1186 | Q13085 | |
| SSSQTPHPPSQRMRR | 11 | Q86VQ1 | |
| PHPPSQRMRRSAAGS | 16 | Q86VQ1 | |
| TPMAPGGSTHRRDRQ | 491 | Q9Y2X7 | |
| SRHRAPRNARMSAPS | 786 | Q9C0C7 | |
| QASITHPRMPGARSL | 396 | Q9UI36 | |
| ARNSSRPERDMHSLP | 281 | Q9NRI5 | |
| RTPHRIILSGSPMQN | 666 | Q03468 | |
| VRNMGPRNTSAHSRP | 701 | Q96QP1 | |
| GHNRSPLVRRPSLQM | 511 | P54802 | |
| MGPRSGEHQRASRIP | 26 | Q6GTS8 | |
| MLAGLRRSHAPQSRS | 561 | Q9NSA2 | |
| QMPTIADRSAAPHSR | 371 | Q96LI6 | |
| RSSPDNSPVHGMLRQ | 976 | Q12791 | |
| GQPSDMVNDHQPSRR | 346 | Q6NUN7 | |
| RPTAAPRSMTHAKRA | 26 | Q9NQW6 | |
| RMGSSQRRTGPSKQH | 441 | P56696 | |
| HSAGTPRAESPMSRQ | 46 | Q6ZUT6 | |
| QMRRPTGTQDSPART | 1556 | P13942 | |
| RSKMGSRPTNDASPR | 261 | Q8N7G0 | |
| MGTRSRAQGHRPQLP | 481 | B2RXH2 | |
| PTSPMAGRRHAATNK | 346 | Q9BRS8 | |
| SLQRNSMSPGVTHRP | 176 | Q06413 | |
| QDRFSPTMGRHRSNQ | 391 | P78344 | |
| LRGNTRPMHPIQQSR | 231 | O15265 | |
| RMHRQRSPTQSPPAD | 1246 | Q86UR5 | |
| MVQAVNQRGRSPRSP | 1091 | Q8WX93 | |
| PRVMQRATSNLHRGP | 316 | Q86VR8 | |
| QRPTGRPTSARQAMG | 1426 | O95996 | |
| IGGTRMPTRSHRNPV | 941 | Q659A1 | |
| PFRQHEMQSPRTAVR | 291 | Q53HC5 | |
| SPVQQGPGMSREQRR | 1316 | Q5JV73 | |
| SQQHPSVPRRMTPGR | 986 | Q4ZHG4 | |
| MSQRVRRNGSPTPAG | 1 | Q6P1L5 | |
| SVRMRDLRNPHPSSA | 21 | P53004 | |
| HPSPVSRVRGNRMNN | 271 | Q9Y4X4 | |
| HNRRSRGMVQSSSPI | 1066 | Q9Y613 | |
| VDGPRMQASAHVTRP | 296 | Q5T4B2 | |
| RPPTQRRMAAGNHST | 11 | Q8NGG7 | |
| NHRARVTTRMGNTPD | 266 | Q8NBJ7 | |
| QVIRQMHPTPGRGSR | 206 | Q8WV44 | |
| MGNSHCVPQAPRRLR | 1 | Q494U1 | |
| PGPNSRRANMHIRDF | 811 | Q8IZX4 | |
| SSPQGIRSRMPTQHL | 661 | Q8NE18 | |
| RRSNMGHKEPRNPNC | 931 | P0DKV0 | |
| NPNLSNRRGSTPLHM | 511 | P57078 | |
| NRDHRGGMQPCSPQR | 256 | Q7Z7G1 | |
| PNSRIMIHQPSGGAR | 171 | Q16740 | |
| ASRRGQPASPSAHMV | 266 | Q14135 | |
| LPQAMGTRHTNSPRI | 306 | Q5VZI3 | |
| MHVRNVGNPSDLPRT | 571 | Q8IYI8 | |
| RAMQANRSQLHSPPG | 36 | Q5M7Z0 | |
| MPQASEHRLGRTREP | 1 | Q9UK80 | |
| QPSPVMTRRGLRDSH | 141 | Q5JTV8 | |
| SRDQPGQAPMRQRSA | 721 | Q6GYQ0 | |
| GSEPHMRTRNQGRRT | 1761 | Q8WWQ0 | |
| RPGMASRVRTPTSQQ | 151 | B3KS81 | |
| MNSTPRNAQAPSHRE | 1 | Q8IWN7 | |
| PMSNRRRHTGSRANP | 101 | Q13595 | |
| MASNRQRSLRGPSHP | 1 | A6NCN8 | |
| GHRASPNPVAMETRS | 461 | Q9H0E3 | |
| PMPNRGTHNCRNRNS | 926 | Q9Y2I1 | |
| SQNASRGRRQRRMHP | 21 | Q9BXY4 | |
| MLHQPTPGNRGLTAR | 1 | P0CG23 | |
| GQPMRTHTLTSRNLP | 1531 | Q7Z7G8 | |
| PSESRSGSNPNRVRM | 96 | P18887 | |
| RTNLNMPHSLPQRSG | 416 | Q8TF42 | |
| MSTRRRHVGNRANPD | 101 | P62995 | |
| PRSSQRVLPMGIQHS | 61 | P51864 | |
| GPSRHQAQGMPRVRA | 311 | Q6ZMS7 | |
| ASDPGRRVQHNMLSP | 741 | Q9P2D8 | |
| TMSTHPSRRRPNGRR | 1141 | Q9NR99 | |
| NHEGSSQRMPRQPSA | 126 | Q6P582 | |
| SREGSSQRMPRQPSA | 126 | Q6NZ67 |